Amgen at Robert W. Baird & Co., Inc. Growth Stock Conference Transcript - Transcript - 2008/05/14 - Thomson StreetEvents

The Premium Business Information Source™

Thomson StreetEvents

Title:	Amgen at Robert W. Baird & Co., Inc. Growth Stock Conference Transcript
Price:	$54.00
Publication Date:	May 14, 2008
Source:	Thomson StreetEvents
Company:	Amgen
Report Type:	Transcript
Abstract:	Final Transcript of AMGN presentation, 14-May-08 8:55am CT
Brief Excerpt:	... - Robert W. Baird & Co., Inc. - AnalystOkay I think we're going to go ahead and get started. My name is Chris Raymond; I cover biotechnology for Robert Baird. Our next presenter today is Amgen, which is a large-cap bellwether -- it was originally founded on the principal of recombinant protein development. The Company was built on the success of its ESA and CSF, or colony stimulating factor supportive care franchises.Its third-biggest franchise, which is a drug called Enbrel is used to treat rheumatoid arthritis and psoriasis and other inflammatory conditions.Looking forward, we see promise in recently-approved Vectibix, and other pipeline candidates including Denosumab, which is an exciting drug for Osteoporosis and also certain cancer indications. With us today is Arvin Sood, Vice President of Investor Relations, and before I go any further, I'll just turn over the floor to Arvin. ...
Word Count:	5672
Length:	9 Pages
Ticker:	AMGN
Time:	8:55am CT
Related Report(s):	Amgen with Glenn Begley at Thomson Reuters Health Summit Transcript: $54.00 Final Transcript of AMGN presentation, 18-Nov-08 9:00am ET Amgen at Credit Suisse Group Healthcare Conference Transcript: $54.00 Final Transcript of AMGN presentation, 14-Nov-08 8:00am MT Business Review Meeting Transcript: $54.00 Final Transcript of AMGN event, 7-Nov-08 8:00am ET Amgen Q3 2008 Earnings Conference Call Summary: $54.00 Edited Brief of AMGN earnings conference call or presentation, 22-Oct-08 4:30pm ET Amgen Q3 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of AMGN earnings conference call or presentation, 22-Oct-08 4:30pm ET Amgen at UBS Global Life Sciences Conference Transcript: $54.00 Final Transcript of AMGN presentation, 23-Sep-08 10:30am ET Amgen at Merrill Lynch Global Pharmaceutical Biotech & Medical Devices Conference Transcript: $54.00 Final Transcript of AMGN presentation, 18-Sep-08 9:50am UKT AMGEN Investor Reception at American Society of Bone and Mineral Research (ASBMR) Transcript: $54.00 Final Transcript of AMGN corporate analyst meeting, 16-Sep-08 12:00pm ET
Format:	Adobe Acrobat
Free Sample:	Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"



Price: $54.00

Looking For Something Else?

Search the Alacra Store

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

about us

public company index

private company index

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.